Second Suns: Two Trailblazing Doctors and Their Quest to Cure Blindness, One Pair of Eyes at a Time
Description:
The publisher will donate a portion of its proceeds on the sale of this book to the Himalayan Cataract Project.
Second Suns is the unforgettable true story of two very different doctors with a common mission: to rid the world of preventable blindness. Dr. Geoffrey Tabin was the high-achieving “bad boy” of his class at Harvard Medical School. Dr. Sanduk Ruit grew up in a remote village in the Himalayas, where cataract blindness—easily curable in modern hospitals—amounts to an epidemic. Together, they pioneered a new surgical method, by which they have helped restore sight to over 4 million people—all for about $20 per operation.
#1 New York Times–bestselling author David Oliver Relin brings the doctors’ work to vivid life through poignant portraits of their patients, from old men who can once again walk treacherous mountain trails, to children who can finally see their mothers’ faces. The Himalayan Cataract Project is changing the world—one pair of eyes at a time.
Best prices to buy, sell, or rent ISBN 9781615193622
Frequently Asked Questions about Second Suns: Two Trailblazing Doctors and Their Quest to Cure Blindness, One Pair of Eyes at a Time
The price for the book starts from $6.23 on Amazon and is available from 35 sellers at the moment.
If you’re interested in selling back the Second Suns: Two Trailblazing Doctors and Their Quest to Cure Blindness, One Pair of Eyes at a Time book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Second Suns: Two Trailblazing Doctors and Their Quest to Cure Blindness, One Pair of Eyes at a Time book, the best buyback offer comes from and is $ for the book in good condition.
Second Suns: Two Trailblazing Doctors and Their Quest to Cure Blindness, One Pair of Eyes at a Time book is in low demand now as the rank for the book is 355,542 at the moment. It's a low rank, and the book has not much sales on Amazon.
Not enough insights yet.